[1]
S. Buti, M. Donini, and S. Lazzarelli, et al., “A new modified schedule of Sunitinib for metastatic renal cell carcinoma: a retrospective analysis”, Acta Biomed, vol. 83, no. 2, pp. 88–94, Oct. 2012, Accessed: Jul. 27, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/2367